Lu, W.; Lin, J.; He, Y.; Yang, B.; Qiu, F.; Dai, Z.
Immunoregulation by ESAT-6: From Pathogenesis of Tuberculosis to Potential Anti-Inflammatory and Anti-Rejection Application. Pharmaceuticals 2025, 18, 1408.
https://doi.org/10.3390/ph18091408
AMA Style
Lu W, Lin J, He Y, Yang B, Qiu F, Dai Z.
Immunoregulation by ESAT-6: From Pathogenesis of Tuberculosis to Potential Anti-Inflammatory and Anti-Rejection Application. Pharmaceuticals. 2025; 18(9):1408.
https://doi.org/10.3390/ph18091408
Chicago/Turabian Style
Lu, Weihui, Jingru Lin, Yuming He, Bin Yang, Feifei Qiu, and Zhenhua Dai.
2025. "Immunoregulation by ESAT-6: From Pathogenesis of Tuberculosis to Potential Anti-Inflammatory and Anti-Rejection Application" Pharmaceuticals 18, no. 9: 1408.
https://doi.org/10.3390/ph18091408
APA Style
Lu, W., Lin, J., He, Y., Yang, B., Qiu, F., & Dai, Z.
(2025). Immunoregulation by ESAT-6: From Pathogenesis of Tuberculosis to Potential Anti-Inflammatory and Anti-Rejection Application. Pharmaceuticals, 18(9), 1408.
https://doi.org/10.3390/ph18091408